A Randomised, Double-Blind, Dose Ranging Clinical Trial of Intravenous FDY-5301 in Acute STEMI Patients Undergoing Primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following Ischemia REperfusion) StudyDavid Adlam, CCC-ACS Investigators, N. Uren et al.|Circulation|2019Cited by 1
Prevention and Management of Percutaneous Coronary Intervention‐Related Complications: Assessing the Impact of Simulation‐Based Learning and Human Factors TrainingJunichi Fukamizu, Tom Johnson, Ryouta Tanetani et al.|Catheterization and Cardiovascular Interventions|2025Cited by 0